Literature DB >> 409728

Elevated basal growth hormone levels and growth hormone response to TRH in alcoholic patients with cirrhosis.

A Zanoboni, W Zanoboni-Muciaccia.   

Abstract

Basal plasma growth hormone (GH) and GH responses after the administration of thyrotropin releasing hormone (TRH) were studied in 9 male alcoholic patients with cirrhosis. Basal GH was significantly higher in cirrhotic patients than in normal men. Intravenous injection of synthetic TRH (400 microgram) caused a significant increase in plasma GH in 7 out of the 9 cirrhotic patients examined, while it did not increase GH levels in normal subjects.

Entities:  

Mesh：

Substances：

Year:  1977        PMID： 409728     DOI： 10.1210/jcem-45-3-576

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN： 0021-972X            Impact factor:   5.958


  13 in total

1.  Effects of intravenous TRH on growth hormone and cortisol serum levels in children and adolescents with insulin dependent diabetes mellitus.

Authors:  M Vanelli; S Bernasconi; O Bolondi; C Mamì; E Pandullo; M Scaffidi; M F Siracusano; F De Luca
Journal:  J Endocrinol Invest       Date:  1986-08       Impact factor: 4.256

Review 2.  Some current aspects of clinical and experimental neuroendocrinology with particular reference to growth hormone, thyrotropin and prolactin.

Authors:  M F Scanlon; M Pourmand; A M McGregor; M D Rodriguez-Arnao; K Hall; A Gomez-Pan; R Hall
Journal:  J Endocrinol Invest       Date:  1979 Jul-Sep       Impact factor: 4.256

3.  Inappropriate growth-hormone (GH) response to thyrotropin-releasing hormone (TRH) occurs infrequently in well-regulated diabetes mellitus.

Authors:  O Giampietro; M Ferdeghini; R Miccoli; G Gregori; G Penno; S Bertoli; R Navalesi
Journal:  Acta Diabetol Lat       Date:  1990 Apr-Jun

4.  Thyroid and pituitary hormone responses to TRH in advanced nonalcoholic liver disease.

Authors:  D H Van Thiel; R Tarter; J S Gavaler; R R Schade; A Sanghvi
Journal:  J Endocrinol Invest       Date:  1986-12       Impact factor: 4.256

5.  Hypothalamic-pituitary dopaminergic function in hepatic failure in man.

Authors:  S Lal; M Oravec; A Aronoff; M E Kiely; H Guyda; S Solomon; N P Nair
Journal:  J Neural Transm       Date:  1982       Impact factor: 3.575

Review 6.  Involvement of brain catecholamines and acetylcholine in growth hormone hypersecretory states. Pathophysiological, diagnostic and therapeutic implications.

Authors:  E E Müller; M Rolla; E Ghigo; D Belliti; E Arvat; A Andreoni; A Torsello; V Locatelli; F Camanni
Journal:  Drugs       Date:  1995-11       Impact factor: 9.546

7.  Lack of dissociation of prolactin responses to thyrotropin releasing hormone and metoclopramide in chronic alcoholic men.

Authors:  D H Van Thiel; J S Gavaler; A Sanghvi
Journal:  J Endocrinol Invest       Date:  1982 Sep-Oct       Impact factor: 4.256

8.  Effect of metoclopramide on serum growth hormone levels in cirrhotic men.

Authors:  R Volpi; V Coiro; M Salvi; G Pelosi; P Mancini; P Chiodera
Journal:  J Endocrinol Invest       Date:  1983-04       Impact factor: 4.256

9.  Failure of nomifensine to reduce serum prolactin levels in patients with hepatic encephalopathy.

Authors:  A Masala; S Alagna; P P Rovasio; A Deplano; V Anania; L Chiandussi; M Langer
Journal:  J Endocrinol Invest       Date:  1985-02       Impact factor: 4.256

10.  Inhibitory influence of thyrotropin releasing hormone administration on growth hormone response to low doses of growth hormone-releasing hormone in normal man.

Authors:  A Zanoboni; M Gibillini; M R Cucchi; W Zanoboni Muciaccia; C Zanussi
Journal:  J Endocrinol Invest       Date:  1988-06       Impact factor: 4.256
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.